LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Focus Clinical-stage dermatology company with a pipeline targeting hyperhidrosis and other skin conditions presents a doorway for potential licensing, collaboration, or acquisition opportunities with larger pharma seeking dermatology growth and first-in-class assets.

Partnership Momentum Past and ongoing collaborations with Kaken Pharmaceutical and AnGes indicate openness to JV and licensing models; explore co-development, regional rights, or milestone-driven deals to monetize assets and expand geographic reach.

LeadershipExperience Executive team has глубок experience in product development and global commercialization from big pharma, suggesting credibility for strategic alliances, joint ventures, and accelerated path to late-stage milestones.

FinancialPosition Small revenue base under $1M with modest funding around $48M implies appetite for partnering to advance programs, de-risk assets, or provide non-dilutive funding through collaborations.

AssetDisposition Recent asset sale of sofpironium bromide to Botanix signals potential for selective asset divestitures; approach with acquisition inquiries, in-license opportunities, or asset-mairketed carve-outs aligned with Brickell’s dermatology focus.

Similar companies to Brickell Biotech, Inc.

Brickell Biotech, Inc. Tech Stack

Brickell Biotech, Inc. uses 8 technology products and services including Amazon Web Services, WordPress, CookieYes, and more. Explore Brickell Biotech, Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • WordPress
    Content Management System
  • CookieYes
    Cookie Compliance
  • Babel
    Development
  • core-js
    Javascript Libraries
  • jQuery Mobile
    Mobile Frameworks
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines

Media & News

Brickell Biotech, Inc.'s Email Address Formats

Brickell Biotech, Inc. uses at least 4 email formats:
Brickell Biotech, Inc. Email FormatsExamplePercentage
FLast@brickellbio.comJDoe@brickellbio.com
86%
First.Last@brickellbio.comJohn.Doe@brickellbio.com
6%
LFirst@brickellbio.comDJohn@brickellbio.com
5%
First@brickellbio.comJohn@brickellbio.com
3%

Frequently Asked Questions

What is Brickell Biotech, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Brickell Biotech, Inc.'s main corporate office by phone at
+1-720-505-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Brickell Biotech, Inc.'s official website and social media links?

Minus sign iconPlus sign iconBrickell Biotech, Inc.'s official website is brickellbio.com and has social profiles on LinkedIn.

How much revenue does Brickell Biotech, Inc. generate?

Minus sign iconPlus sign icon As of July 2026, Brickell Biotech, Inc.'s annual revenue is estimated to be <$1M.

What is Brickell Biotech, Inc.'s SIC code?

Minus sign iconPlus sign iconBrickell Biotech, Inc.'s SIC code is 2834 - Pharmaceutical Preparations.

How many employees does Brickell Biotech, Inc. have currently?

Minus sign iconPlus sign iconAs of July 2026, Brickell Biotech, Inc. has approximately 20 employees across 1 continents, including North America. Key team members include Vice President, Head Of Clinical Operations: N. S., Director: C. B. and General Manager: K. H. Explore Brickell Biotech, Inc.'s employee directory with LeadIQ.

What industry does Brickell Biotech, Inc. belong to?

Minus sign iconPlus sign iconBrickell Biotech, Inc. operates in the Pharmaceuticals industry.

What technology does Brickell Biotech, Inc. use?

Minus sign iconPlus sign iconBrickell Biotech, Inc.'s tech stack includes Amazon Web Services, WordPress, CookieYes, Babel, core-js, jQuery Mobile, PHP and Yoast SEO.

What is Brickell Biotech, Inc.'s email format?

Minus sign iconPlus sign iconBrickell Biotech, Inc.'s email format typically follows the pattern of FLast@brickellbio.com. Find more Brickell Biotech, Inc. email formats with LeadIQ.

How much funding has Brickell Biotech, Inc. raised to date?

Minus sign iconPlus sign icon As of July 2026, Brickell Biotech, Inc. has raised $48M in funding. The last funding round occurred on Jul 19, 2021 for $8.1M.

When was Brickell Biotech, Inc. founded?

Minus sign iconPlus sign iconBrickell Biotech, Inc. was founded in 2009.
Brickell Biotech, Inc. logo

Brickell Biotech, Inc.

PharmaceuticalsColorado, United States11-50 Employees

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing prescription therapeutics for dermatologic diseases, with an emphasis on conditions such as hyperhidrosis and other prevalent skin disorders. Its pipeline centers on novel therapies aimed at non-invasive or differentiated treatment approaches, addressing unmet needs in the global dermatology market. Based in Boulder, Colorado, the company operates within the pharmaceutical manufacturing industry and pursues in-licensing, acquisitions, development, and eventual commercialization of innovative dermatology-focused products.

Brickell emphasizes executive and board leadership with extensive experience in product development and global commercialization, underscoring its strategy to leverage established expertise to advance therapies through development and potential future markets. The company engages in collaborations and partnerships to support its clinical program progression and has pursued relationships with other pharmaceutical entities to advance its research initiatives in dermatology and related autoimmune or debilitating diseases. The most recent publicly noted developments include asset disposition related to a skin-related treatment, illustrating ongoing portfolio and collaboration activity in the field.

Section iconCompany Overview

Phone number
+1-720-505-****
Website
brickellbio.com
SIC Code
2834 - Pharmaceutical Preparations
Founded
2009
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $48M

    Brickell Biotech, Inc. has raised a total of $48M of funding over 6 rounds. Their latest funding round was raised on Jul 19, 2021 in the amount of $8.1M as a Post IPO Equity.

  • <$1M

    Brickell Biotech, Inc.'s revenue is estimated to be in the range of <$1M

Company Leadership

  • Vice President, Head Of Clinical Operations at Brickell Biotech, Inc.
    N. S.
    Vice President, Head Of Clinical Operations
    Mobile Phone
  • Director at Brickell Biotech, Inc.
    C. B.
    Director
    Mobile Phone
  • General Manager at Brickell Biotech, Inc.
    K. H.
    General Manager
    Mobile Phone
  • Associate Director Human Resources at Brickell Biotech, Inc.
    M. F.
    Associate Director Human Resources
    Mobile Phone
  • Legal Assistant & Contracts Administrator at Brickell Biotech, Inc.
    K. M.
    Legal Assistant & Contracts Administrator
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.